Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Sedegah, Martha ^a   Kim, Yohan ^b   Peters, Bjoern ^b   McGrath, Shannon ^c   Ganeshan, Harini ^a,d   Lejano, Jennylynn ^a,d   Abot, Esteban ^a,d   Banania, Glenna ^a,d   Belmonte, Maria ^a,d   Sayo, Renato ^a,d   Farooq, Fouzia ^a,d   Doolan, Denise L ^e   Regis, David ^a   Tamminga, Cindy ^a   Chuang, Ilin ^a   Bruder, Joseph T ^f   King, C Richter ^f   Ockenhouse, Christian F ^c   Faber, Bart ^g   Remarque, Edmond ^g   Hollingdale, Michael R ^h   Richie, Thomas L ^a   Sette, Alessandro ^b   more..

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f GenVec   (United States)

^g BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^h NMRC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; APICAL MEMBRANE ANTIGEN 1; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MALARIA VACCINE; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ADULT; ALGORITHM; ALLELE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPUTER PROGRAM; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALARIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SEROTYPE; T CELL DEPLETION; VACCINATION; GENE VECTOR; GENETICS; HUMAN ADENOVIRUS; HUMAN EXPERIMENT; IMMUNOLOGY; SECRETION;

ADENOVIRUSES, HUMAN; ADULT; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; HUMAN EXPERIMENTATION; HUMANS; INTERFERON-GAMMA; MALARIA VACCINES; MEMBRANE PROTEINS; PROTOZOAN PROTEINS;

EID: 77955837345     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-241     Document Type: Article

References (70)

1. Immune response to pre-erythrocytic stages of malaria parasites. DL Doolan N Martinez-Alier, Curr Mol Med 2006 6 2 169 185 10.2174/ 156652406776055249 16515509
2. Recent insights into humoral and cellular immune responses against malaria. JG Beeson FH Osier CR Engwerda, Trends Parasitol 2008 24 12 578 584 10.1016/j.pt.2008.08.008 18848497
3. Cellular effector mechanisms against Plasmodium liver stages. U Frevert E Nardin, Cell Microbiol 2008 10 10 1956 1967 10.1111/j.1462-5822.2008.01211.x 18647171
4. Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. SE Bongfen R Torgler JF Romero L Renia G Corradin, J Immunol 2007 178 11 7054 7063 17513754
5. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. A Trimnell A Takagi M Gupta TL Richie SH Kappe R Wang, J Immunol 2009 183 9 5870 5878 10.4049/jimmunol.0900302 19812194
6. Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii. CT Williams AF Azad, PLoS One 2010 5 4 10267 10.1371/journal.pone.0010267 20422005
7. Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. VS Moorthy WR Ballou, Malar J 2009 8 1 312 10.1186/1475-2875-8-312 20042088
8. Development of the RTS, S/AS malaria candidate vaccine. J Vekemans A Leach J Cohen, Vaccine 2009 27 Suppl 6 67 71 10.1016/j.vaccine.2009.10.013 20006143
9. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. M Mauduit R Tewari N Depinay M Kayibanda E Lallemand JM Chavatte G Snounou L Renia AC Gruner, Infect Immun 2010 78 5 2182 2188 10.1128/IAI.01415-09 20194600
10. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. KA Kumar G Sano S Boscardin RS Nussenzweig MC Nussenzweig F Zavala V Nussenzweig, Nature 2006 444 7121 937 940 10.1038/nature05361 17151604
11. Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS, S/AS01B and RTS, S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection. KE Kester JF Cummings O Ofori-Anyinam CF Ockenhouse U Krzych P Moris R Schwenk RA Nielsen Z Debebe E Pinelis,, et al. J Infect Dis 2009 200 3 337 346 10.1086/600120 19569965
12. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS, S/AS02 D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. A Barbosa D Naniche JJ Aponte MN Manaca I Mandomando P Aide J Sacarlal M Renom S Lafuente WR Ballou,, et al. Infect Immun 2009 77 10 4502 4509 10.1128/IAI.00442-09 19651872
13. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. A Saul G Lawrence A Allworth S Elliott K Anderson C Rzepczyk LB Martin D Taylor DP Eisen DO Irving,, et al. Vaccine 2005 23 23 3076 3083 10.1016/j.vaccine.2004.09.040 15811655 (Pubitemid 40462448)
14. Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial. MA Thera OK Doumbo D Coulibaly DA Diallo AK Kone AB Guindo K Traore A Dicko I Sagara MS Sissoko,, et al. PLoS ONE 2008 3 1 1465 10.1371/journal.pone.0001465 18213374
15. Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children. A Dicko I Sagara RD Ellis K Miura O Guindo B Kamate M Sogoba MB Niambele M Sissoko M Baby,, et al. PLoS ONE 2008 3 2 1563 10.1371/journal.pone. 0001563 18270560
16. Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells. MC Huaman GE Mullen CA Long S Mahanty, Vaccine 2009 27 5239 5246 10.1016/j.vaccine.2009.06.066 19591795
17. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. MD Spring JF Cummings CF Ockenhouse S Dutta R Reidler E Angov E Bergmann-Leitner VA Stewart S Bittner L Juompan,, et al. PLoS One 2009 4 4 5254 10.1371/journal.pone.0005254 19390585
18. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. EM Malkin DJ Diemert JH McArthur JR Perreault AP Miles BK Giersing GE Mullen A Orcutt O Muratova M Awkal,, et al. Infect Immun 2005 73 6 3677 3685 10.1128/IAI.73.6.3677-3685.2005 15908397
19. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. T Triglia J Healer SR Caruana AN Hodder RF Anders BS Crabb AF Cowman, Mol Microbiol 2000 38 4 706 718 10.1046/j.1365-2958.2000.02175.x 11115107
20. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. CR Collins C Withers-Martinez GA Bentley AH Batchelor AW Thomas MJ Blackman, J Biol Chem 2007 282 10 7431 7441 10.1074/jbc.M610562200 17192270
21. Specificity of the protective antibody response to apical membrane antigen 1. AN Hodder PE Crewther RF Anders, Infect Immun 2001 69 5 3286 3294 10.1128/IAI.69.5.3286-3294.2001 11292751
22. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. SD Polley T Mwangi CH Kocken AW Thomas S Dutta DE Lanar E Remarque A Ross TN Williams G Mwambingu,, et al. Vaccine 2004 23 5 718 728 10.1016/j.vaccine.2004.05.031 15542195
23. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. AM Coley NV Campanale JL Casey AN Hodder PE Crewther RF Anders LM Tilley M Foley, Protein Eng 2001 14 9 691 698 10.1093/protein/14.9.691 11707616
24. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. AM Coley K Parisi R Masciantonio J Hoeck JL Casey VJ Murphy KS Harris AH Batchelor RF Anders M Foley, Infect Immun 2006 74 5 2628 2636 10.1128/IAI.74.5.2628-2636.2006 16622199
25. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. AW Stowers MC Kennedy BP Keegan A Saul CA Long LH Miller, Infect Immun 2002 70 12 6961 6967 10.1128/IAI.70.12.6961-6967.2002 12438375
26. Apical membrane antigen 1: a malaria vaccine candidate in review. EJ Remarque BW Faber CH Kocken AW Thomas, Trends Parasitol 2008 24 2 74 84 10.1016/j.pt.2007.12.002 18226584
27. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. O Silvie JF Franetich S Charrin MS Mueller A Siau M Bodescot E Rubinstein L Hannoun Y Charoenvit CH Kocken,, et al. J Biol Chem 2004 279 10 9490 9496 10.1074/jbc.M311331200 14676185
28. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. JC Pizarro B Vulliez-Le Normand ML Chesne-Seck CR Collins C Withers-Martinez F Hackett MJ Blackman BW Faber EJ Remarque CH Kocken,, et al. Science 2005 308 5720 408 411 10.1126/science.1107449 15731407
29. Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. ML Chesne-Seck JC Pizarro B Vulliez-Le Normand CR Collins MJ Blackman BW Faber EJ Remarque CH Kocken AW Thomas GA Bentley, Mol Biochem Parasitol 2005 144 1 55 67 10.1016/j.molbiopara.2005.07.007 16154214
30. Structural basis of antigenic escape of a malaria vaccine candidate. S Dutta SY Lee AH Batchelor DE Lanar, Proc Natl Acad Sci USA 2007 104 30 12488 12493 10.1073/pnas.0701464104 17636123
31. Molecular vaccines for malaria. JT Bruder E Angov KJ Limbach TL Richie, Hum Vaccin 2010 6 1 54 77 10.4161/hv.6.1.10463 20061792
32. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. T Bai M Becker A Gupta P Strike VJ Murphy RF Anders AH Batchelor, Proc Natl Acad Sci USA 2005 102 36 12736 12741 10.1073/pnas.0501808102 16129835
33. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. A Ouattara J Mu S Takala-Harrison R Saye I Sagara A Dicko A Niangaly J Duan RD Ellis LH Miller,, et al. Malar J 2010 9 1 175 10.1186/1475-2875-9-175 20565971
34. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. SL Takala CV Plowe, Parasite Immunol 2009 31 9 560 573 10.1111/j.1365-3024.2009.01138.x 19691559
35. Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning. KS Harris JL Casey AM Coley JA Karas JK Sabo YY Tan O Dolezal RS Norton AB Hughes D Scanlon,, et al. J Biol Chem 2009 284 14 9361 9371 10.1074/jbc.M808762200 19164290
36. Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria. AA Lal MA Hughes DA Oliveira C Nelson PB Bloland AJ Oloo WE Hawley AW Hightower BL Nahlen V Udhayakumar, Infect Immun 1996 64 3 1054 1059 8641760
37. Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. N Abboud M De Jesus A Nakouzi RJ Cordero M Pujato A Fiser J Rivera A Casadevall, J Biol Chem 2009 284 37 25077 25086 10.1074/jbc.M109.022061 19617628
38. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. D Corti AL Suguitan D Pinna C Silacci BM Fernandez-Rodriguez F Vanzetta C Santos CJ Luke FJ Torres-Velez NJ Temperton,, et al. J Clin Invest 2010 120 5 1663 1673 20389023
39. Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum. C Li R Wang Y Wu D Zhang Z He W Pan, Malar J 2010 9 1 94 10.1186/1475-2875-9-94 20384992
40. Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses. T Senger MR Becker L Schadlich T Waterboer L Gissmann, J Virol 2009 83 24 12692 12701 10.1128/JVI.01582-09 19793806
41. Epitope mapping and cross-reactivity analysis of the monoclonal antibodies against hexon protein of human adenovirus type 3. H Qiu Z Zhou K Feng X Tian X Li H Li K Xing J Chen C Li R Zhou, Virus Res 2009 146 1-2 58 65 10.1016/j.virusres.2009.08.011 19732803
42. Monoclonal antibodies to the West Nile virus NS5 protein map to linear and conformational epitopes in the methyltransferase and polymerase domains. RA Hall SE Tan B Selisko R Slade J Hobson-Peters B Canard M Hughes JY Leung E Balmori-Melian S Hall-Mendelin,, et al. J Gen Virol 2009 90 Pt 12 2912 2922 10.1099/vir.0.013805-0 19710254
43. Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. V Udhayakumar S Kariuki M Kolczack M Girma JM Roberts AJ Oloo BL Nahlen AA Lal, Am J Trop Med Hyg 2001 65 2 100 107 11508382
44. Epitope mapping of antibodies using a cell array-based polypeptide library. RH Maier CJ Maier R Rid H Hintner JW Bauer K Onder, J Biomol Screen 2010 15 4 418 426 10.1177/1087057110363821 20233905
45. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. R Singh S Singh PK Sharma UP Singh DE Briles SK Hollingshead JW Lillard Jr, PLoS One 2010 5 2 9432 10.1371/journal.pone.0009432 20195541
46. Mapping of Taenia solium TSOL18 antigenic epitopes by phage display library. A Guo X Cai W Jia B Liu S Zhang P Wang H Yan X Luo, Parasitol Res 2010 106 5 1151 1157 10.1007/s00436-010-1786-1 20177903
47. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. Y Chen Y Pan Y Guo L Qiu X Ding X Che, Virology 2010 398 2 290 298 10.1016/j.virol.2009.12.010 20079511
48. Phage display selection, analysis, and prediction of B cell epitopes. NT Freund D Enshell-Seijffers JM Gershoni, Curr Protoc Immunol 2009 Chapter 9 Unit 9 8 19653209
49. IMMUNOCAT-a data management system for epitope mapping studies. JL Chung J Sun J Sidney A Sette B Peters, J Biomed Biotechnol 2010 2010 856842 20490281
50. SAROTUP: scanner and reporter of target-unrelated peptides. J Huang B Ru S Li H Lin FB Guo, J Biomed Biotechnol 2010 2010 101932 20339521
51. In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. L Moise JA McMurry S Buus S Frey WD Martin AS De Groot, Vaccine 2009 27 46 6471 6479 10.1016/j.vaccine.2009.06.018 19559119
52. SEPPA: a computational server for spatial epitope prediction of protein antigens. J Sun D Wu T Xu X Wang X Xu L Tao YX Li ZW Cao, Nucleic Acids Res 2009 37 Web Server 612 616 10.1093/nar/gkp417 19465377
53. Identification of human MHC class I binding peptides using the iTOPIA- epitope discovery system. M Wulf P Hoehn P Trinder, Methods Mol Biol 2009 524 361 367 19377958
54. NetMHCpan, a method for MHC class I binding prediction beyond humans. I Hoof B Peters J Sidney LE Pedersen A Sette O Lund S Buus M Nielsen, Immunogenetics 2009 61 1 1 13 10.1007/s00251-008-0341-z 19002680
55. Epitope mapping: the first step in developing epitope-based vaccines. JM Gershoni A Roitburd-Berman DD Siman-Tov N Tarnovitski Freund Y Weiss, BioDrugs 2007 21 3 145 156 10.2165/00063030-200721030-00002 17516710
56. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. M Nielsen C Lundegaard P Worning SL Lauemoller K Lamberth S Buus S Brunak O Lund, Protein Sci 2003 12 5 1007 1017 10.1110/ps.0239403 12717023
57. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. R Wang J Epstein FM Baraceros EJ Gorak Y Charoenvit DJ Carucci RC Hedstrom N Rahardjo T Gay P Hobart,, et al. Proc Natl Acad Sci USA 2001 98 19 10817 10822 10.1073/pnas.181123498 11526203
58. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS, S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. VA Stewart SM McGrath PM Dubois MG Pau P Mettens J Shott M Cobb JR Burge D Larson LA Ware,, et al. Infect Immun 2007 75 5 2283 2290 10.1128/IAI.01879-06 17307942
59. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. M Nielsen C Lundegaard T Blicher B Peters A Sette S Justesen S Buus O Lund, PLoS Comput Biol 2008 4 7 1000107 10.1371/journal.pcbi. 1000107 18604266
60. HLA class I supertypes: a revised and updated classification. J Sidney B Peters N Frahm C Brander A Sette, BMC Immunol 2008 9 1 10.1186/1471-2172-9-1 18211710
61. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. A Sette J Sidney, Immunogenetics 1999 50 3-4 201 212 10.1007/s002510050594 10602880
62. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. R Wang TL Richie MF Baraceros N Rahardjo T Gay JG Banania Y Charoenvit JE Epstein T Luke DA Freilich,, et al. Infect Immun 2005 73 5 2863 2872 10.1128/IAI.73.5.2863-2872.2005 15845492
63. Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. SD Polley W Chokejindachai DJ Conway, Genetics 2003 165 2 555 561 14573469
64. A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas - XVI. Asembo Bay Cohort Project. AA Escalante HM Grebert R Isea IF Goldman L Basco M Magris S Biswas S Kariuki AA Lal, Mol Biochem Parasitol 2002 125 1-2 83 90 10.1016/S0166-6851(02)00216-5 12467976
65. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. A Cortes M Mellombo I Mueller A Benet JC Reeder RF Anders, Infect Immun 2003 71 3 1416 1426 10.1128/IAI.71.3.1416-1426.2003 12595459
66. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. MC Kennedy J Wang Y Zhang AP Miles F Chitsaz A Saul CA Long LH Miller AW Stowers, Infect Immun 2002 70 12 6948 6960 10.1128/IAI.70.12.6948-6960.2002 12438374
67. Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. S Surman TD Lockey KS Slobod B Jones JM Riberdy SW White PC Doherty JL Hurwitz, Proc Natl Acad Sci USA 2001 98 8 4587 4592 10.1073/pnas.071063898 11287644
68. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Y Zevering C Khamboonruang MF Good, Immunology 1998 94 3 445 454 10.1046/j.1365-2567.1998.00514.x 9767430
69. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. EJ Remarque BW Faber CH Kocken AW Thomas, Infect Immun 2008 76 6 2660 2670 10.1128/IAI.00170-08 18378635
70. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. AW Thomas JF Trape C Rogier A Goncalves VE Rosario DL Narum, Am J Trop Med Hyg 1994 51 6 730 740 7810805